Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL

NCT04030195

Conditions
B-cell Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma, Chronic Disease, +25 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Columbia University New York, United States
  • Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

NCT01607892

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +35 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL

NCT02758665

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Universitätsklinikum Köln Cologne, Germany
  • BAG Onkologische Gemeinschaftspraxis Dresden, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
View Trial Details
Completed

Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia

NCT03374137

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Inje University Busan Paik Hospital; Hematology-oncology Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • St. Vincent's Hospital Gyeonggi-do, South Korea
  • Hallym University Sacred Heart Hospital; Department of Hematology Gyeonggi-do, South Korea
View all 17 locations
View Trial Details
Completed

A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy

NCT02141282

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 128535 La Jolla, California, United States
  • University of California, Los Angeles /ID# 127262 Los Angeles, California, United States
  • Stanford University School of Med /ID# 126495 Stanford, California, United States
  • Georgetown University Hospital /ID# 127261 Washington D.C., District of Columbia, United States
View all 15 locations
View Trial Details
Completed

iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL

NCT02802943

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Katharinenhospital Stuttgart, Baden-Wurttemberg, Germany
  • Diakonie-Klinikum Stuttagrt Stuttgart, Baden-Wurttemberg, Germany
  • Marienhospital Stuttgart, Baden-Wurttemberg, Germany
  • Robert-Bosch-Krankenhaus Abteilung fuer Haematologie, Onkologie und Palliativmedizin Stuttgart, Baden-Wurttemberg, Germany
View Trial Details

Related conditions